News

TECHALT INC'S STAN'S RODEO OINTMENT Launches National Ad Campaign at MLB World Series!

SEATTLE-(Business Wire)-October 2, 2008 - Techalt, Inc.’s (Pink Sheets: TECA) (“Techalt” or “Company”) Stan’s Rodeo Ointment is the choice when premier athletes and savvy consumers have the option for a topical ointment. Stanley Johnston, former Major league Baseball trainer and inventor, has made his product available by prescription since 1980. It has been trusted and used as a preferred choice of treatment for blisters, scrapes, and cuts by Olympic athletes, Professional and Amateur athletes, and moms alike. With OTC (over-the-counter) approval on the plate for 2009-2010, Techalt has commenced the start of a national campaign for the product’s penetration into the Topical Ointment market. They will start with a World Series Program Ad that will give access to over 3 million baseball fans. Dave Moore, President of Techalt, states, “We are serious about our dedication to our portfolio products, and SRO has the potential of capturing a good 10 percent of the $150M topical ointment market. We, here at Techalt, have every intention of doing everything possible to make that a reality!”

The OTC process will take from 18 months to 36 months to complete depending on the amount of information that the FDA will require. During the process, the Company anticipates the Prescription market needs to expand and be marketed to build a base consumer market so that when the product gets OTC approval it has an immediate market share.

SRO is in the same category as Neosporin, Triple Antibiotic Ointment and other topical ointments. Despite the lack of scientific evidence, testimony after testimony of athletes and normal consumers state unequivocally that SRO provides the same barrier of protection as other topical ointments, but with its unique formula the users claim there are benefits of expedience to pain relief and faster healing of the dermal wound.

Techalt is currently in the process of securing financing for (i) expanding SRO’s distribution channels and marketing efforts and (ii) completing the process for obtaining an over-the-counter designation from the United States Food and Drug Administration.

About Stan’s Rodeo Ointment (“SRO”):

SRO is a sports cream product designed to accelerate the healing time for abrasions, lacerations, blisters and other open wounds to the skin while diminishing the pain that often results from such injuries. Developed by Stanley Johnston, former head athletic trainer for the Los Angeles Dodgers, SRO is currently available by prescription and used by prominent Olympic and professional athletes. Techalt also acquired the rights to develop Stan’s Blister Rub (“SBR”), which is a combination of materials that strengthen the skin after it has healed to reduce the likelihood of the reoccurrence of blisters to the applied area. Patent protection has been filed covering the formulations and processing of SRO with the US Patent and Trademark Office. The Company anticipates that a patent will be issued sometime in 2008.

About Techalt:

Techalt is a public holding company dedicated to pursuing acquisition, licensing and financing opportunities with start-up and mid-stage companies. Techalt focuses on companies with innovative or alternative technologies, particularly in the software, communications, environmental and health and wellness sectors.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“the Exchange Act”), as such, may involve risks and uncertainties. Forward-looking statements are based upon certain assumptions and describe future plans, strategies and expectations, are generally identifiable by the use of words as “believe,” “expect,” “intend,” “anticipate,” “project,” or other similar expressions. Forward-looking statements relate to, among other things, future performance, and perceived opportunities in the market and statements regarding the Company’s mission and vision. The Company’s actual results, performance and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements. Additional factors could materially affect these forward-looking statements and/or predictions include, among other things: (1) managing acquisitions and expansion of operations; (2) obtaining necessary financing and managing existing debt; (3) completing the investigation, acquisition and integration of new business opportunities; (4) complying with federal, state and local government and international regulations; and (5) other factors over which we have little or no control.